SEC Form D private-offering filing
NewcelX Ltd.
A new SEC Form D private-offering notice from Kloten, a $3,428,989 filer-stated offering target in Biotech. The source filing is one click away.
Clinical-stage biotechnology company developing cell-based and small-molecule therapies for neurodegenerative and metabolic diseases, including Type 1 diabetes and ALS.
Filed 2026-05-13Filed to raise $3,428,989First money in 2026-04-27Raised so far $3,428,989HQ (as filed) KlotenSector Biotech ✓Stage (inferred) SeedCall status Non-US principal office
Source linked the Form D on EDGAR↗Website verified newcelx.com↗Named in the filing 9 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.